First, we examined formalin-fixed, paraffin-embedded (FFPE) tissue samples from the ovarian tumor of the patient by BRCA1/2 all-exon sequencing and found a point mutation (G>T) in the c.7795 position in the exon 16 of the BRCA2 gene. This evidence concerns the gene BRCA2 and ovarian neoplasm.